ClinicalTrials.Veeva

Menu

Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis (MicroPso)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Psoriasis

Treatments

Other: Laser Doppler recording
Other: ppi water iontophoresis
Other: Sodium Nitroprussiate iontophoresis
Other: Acetylcholine iontophoresis

Study type

Interventional

Funder types

Other

Identifiers

NCT02652065
69HCL15_0425

Details and patient eligibility

About

Psoriasis is a chronic inflammatory cutaneous disease, affecting 3% of the French population. Among psoriatic patients, 80% feel pain or cutaneous discomfort related to their pathology.

Neurogenic inflammation's role in psoriasis has recently been put forward by a study showing that TRPV1 ion channels are necessary to establish psoriasiform inflammation in mice.

The investigators hypothesize that there is a link between cutaneous sensory neuropathies and altered cutaneous microcirculation during psoriasis.

In order to test this hypothesis, local vasodilators will be delivered to patients by iontophoresis and their skin blood flow in response to these molecules will be followed by laser Doppler recordings. Two recordings will be performed for each patient, both on a psoriasis plaque and on uninvolved skin, in order for the patient to be his own internal control.

Enrollment

20 patients

Sex

All

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type I psoriasis
  • Psoriasis plaques on the patient's back

Exclusion criteria

  • BMI > 25
  • Diabetic patient
  • Arteriovenous disease history
  • Ongoing anti-inflammatory treatment
  • Major cardiovascular history (<3 months)
  • Hypertension
  • Topical treatment on the back skin (<7 days)
  • Systemic treatment (steroids, methotrexate, retinoids, cyclosporine) or phototherapy (<1 month)
  • Pregnant women
  • Subject within exclusion period following a previous or ongoing biomedical study

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Healthy skin
Active Comparator group
Description:
Local vasodilators (acetylcholine, sodium nitroprussiate and ppi water as control) will be delivered to patients by iontophoresis on healthy skin. The skin blood flow in response to these molecules will be followed by laser Doppler recordings.
Treatment:
Other: Sodium Nitroprussiate iontophoresis
Other: Acetylcholine iontophoresis
Other: ppi water iontophoresis
Other: Laser Doppler recording
Psoriasis plaque
Experimental group
Description:
Local vasodilators (acetylcholine, sodium nitroprussiate and ppi water as control) will be delivered to patients by iontophoresis on a psoriasis plaque (on the patient's back). The skin blood flow in response to these molecules will be followed by laser Doppler recordings.
Treatment:
Other: Sodium Nitroprussiate iontophoresis
Other: Acetylcholine iontophoresis
Other: ppi water iontophoresis
Other: Laser Doppler recording

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems